Rakuten Aspyrian's Series C Round

Rakuten Aspyrian raised a round of funding on August 23, 2018. Investors include Hiroshi Mikitani.

Rakuten Aspyrian, fka Aspyrian Therapeutics, is a clinical stage biotechnology company with offices in the USA, Japan and Germany, developing new anticancer therapies based on the Photoimmunotherapy p…

Articles about Rakuten Aspyrian's Series C Round: